HSA
IDXX icon

Hussman Strategic Advisors’s Idexx Laboratories IDXX Stock Holding History

Hussman Strategic Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-58,000
Closed -$4.48M – 202
2015
Q1 		$4.48M Sell
58,000
-14,600
-20% -$1.14M 0.47% 83
2014
Q4 		$5.38M Buy
+72,600
New +$5.09M 0.54% 80

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hussman Strategic Advisors's IDXX Position: Q2 2015 in Review

Hussman Strategic Advisors sold out of Idexx Laboratories (IDXX) in Q2 2015, closing a stake of 58,000 shares — an estimated $4.48M sold.

Hussman Strategic Advisors first reported a position in IDXX in Q4 2014 and held it in 2 quarters. The position peaked at $5.38M in Q4 2014. 348 funds tracked by Wall St. Rank hold IDXX as of Q2 2015.

  • Hussman Strategic Advisors reported no remaining Idexx Laboratories position as of Q2 2015 after selling out during the quarter.
  • Hussman Strategic Advisors sold 58,000 Idexx Laboratories shares in Q2 2015, an estimated $4.48M.
  • Hussman Strategic Advisors first reported a position in Idexx Laboratories in Q4 2014 and held it in 2 quarters.
  • Hussman Strategic Advisors's Idexx Laboratories position peaked at $5.38M in Q4 2014.
  • 348 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2015.

Based on Hussman Strategic Advisors's 13F filing for Q2 2015, filed 31 Jul 2015.